Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

The Scotts Miracle-Gro Company (SMG) SEC Filings & Earnings Calls

EquiReason read 22 The Scotts Miracle-Gro Company SEC filings in the last 12 months. Latest: 8-K on 2026-10-16 — Separation agreement with Christopher Hagedorn, indicating departure of a key officer. No financial details or performance impact stated..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SMGThe Scotts Miracle-Gro CompanyFollow SMG — free
Agricultural Inputs · Basic Materials
—
Price chart with a free account
Market cap
3.5B
P/E TTM
50.2
Dividend yield
4.5%
52-week
—
Next earnings
4 Nov, in 11 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

16 Oct 20268-K · 5.02Separation agreement with Christopher Hagedorn, indicating departure of a key officer. No financial details or performance impact stated.open

Risks flagged

Key executive departure could lead to operational disruption or strategic shifts.

“Separation agreement with Christopher Hagedorn”
Read the original on SEC EDGAR ↗
15 Sep 20268-K · 1.02, 8.01Scotts Miracle-Gro terminated a material definitive agreement; no details on counterparty or financial impact provided.open

Risks flagged

Loss of a material agreement may impact revenue or operations; lack of disclosure increases uncertainty.

“Termination of material definitive agreement; no specifics on counterparty, terms, or financial effect.”
Read the original on SEC EDGAR ↗
11 Sep 20268-K · 5.02Board member Adam Hanft retired effective immediately; consulting relationship with Hanft Ideas LLC continues.SEC ↗
3 Sep 20268-K · 5.02Departure of EVP & Chief Strategy Officer Christopher Hagedorn, effective Sept 30, 2026; no successor named, no disagreement disclosed.SEC ↗
27 Aug 20268-K · 1.01Third Amendment to Master Receivables Purchase Agreement with JPMorgan Chase Bank, N.A. – a routine amendment to an existing receivables financing facility, no material change in terms disclosed.SEC ↗
5 Aug 202610-QScotts Miracle-Gro reported Q3 net sales up 1.1% but net income from continuing operations down 33% due to higher impairment charges and lower gross margin.earningsopen

Figures in the filing · each found in the filing text

Net sales · Consolidated · Q3-2026$1.17B+1% y/y
Net sales · Consolidated · 9M-2026$2.99B+2% y/y
Gross margin rate · Consolidated · Q3-202631.2%
Gross margin rate · Consolidated · 9M-202635.7%
Net income from continuing operations · Consolidated · Q3-2026$104M-33% y/y
Net income from continuing operations · Consolidated · 9M-2026$319M+3% y/y
U.S. Consumer segment net sales · U.S. Consumer · Q3-2026$1.03B+0% y/y
U.S. Consumer segment net sales · U.S. Consumer · 9M-2026$2.74B+2% y/y
Other segment net sales · Other · Q3-2026$139M+8% y/y
Other segment net sales · Other · 9M-2026$248M+6% y/y

Risks flagged

Restructuring and impairment charges

“Total impairment, restructuring and other charges, net $ 48.2 $ 1.0 $ 53.5 $ 34.5” · word for word

Hawthorne divestiture loss

“For the nine months ended June 27, 2026, we recorded a loss of $101.8 related to the sale of the Hawthorne business in North America.” · word for word

Macroeconomic and tariff uncertainty

“We continue to monitor the impacts of macroeconomic conditions, including elevated interest rates and inflationary pressures on input costs and consumer behavior, as well as geopolitical uncertainty, including the duration and resolution of ongoing conflicts, potential escalation of tensions and global supply chain disruptions, and ongoing changes to global ” · word for word
Read the original on SEC EDGAR ↗
29 Jul 20268-K · 2.02Net sales $1.17B (+1% y/y); GAAP gross margin rate 31.2; Non-GAAP adjusted gross margin rate 31.3; Guidance: Non-GAAP adjusted EPS guidance raised from $4.15-$4.35 to $4.30-$4.45earningsopen

Figures in the filing · each found in the filing text

Net sales · U.S. Consumer · Q3-2026$1.17B+1% y/y
GAAP gross margin rate · Q3-202631.2%
Non-GAAP adjusted gross margin rate · Q3-202631.3%
GAAP net income from continuing operations per diluted share · Q3-2026$1.75-34% y/y
Non-GAAP adjusted net income from continuing operations per diluted share · Q3-2026$2.82+8% y/y
Net leverage ratio · Q3-2026$3.78
Free cash flow guidance · FY2026$275M

Guidance

Non-GAAP adjusted EPS guidance raised from $4.15-$4.35 to $4.30-$4.45

EPS guidance raised due to margin management and balance sheet strength; demand stable with low single-digit growth; capex investment in automation and AI.

Risks flagged

Higher freight and commodity costs due to Iran conflict pressuring gross margin.

“driven by higher freight and commodity costs resulting from the Iran conflict.” · word for word
Read the original on SEC EDGAR ↗
1 Jul 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen

Risks flagged

CEO departure may create uncertainty, but succession plan suggests orderly transition.

“Long-term succession plan executed; Baxter has been COO since 2024.”
Read the original on SEC EDGAR ↗
6 May 202610-QNet Sales $1.46B (+5% y/y); Gross Margin Rate 41.8; Net Income from Continuing Operations $263M (+19% y/y)open

Figures in the filing · each found in the filing text

Net Sales · Consolidated · Q2-2026$1.46B+5% y/y
Gross Margin Rate · Consolidated · Q2-202641.8%
Net Income from Continuing Operations · Consolidated · Q2-2026$263M+19% y/y
U.S. Consumer Net Sales · U.S. Consumer · Q2-2026$1.38B+5% y/y
U.S. Consumer Segment Profit · U.S. Consumer · Q2-2026$437M+12% y/y
Interest Expense · Consolidated · Q2-2026$31M-15% y/y
Diluted EPS from Continuing Operations · Consolidated · Q2-2026$4.46+18% y/y
Operating Cash Flow · Consolidated · H1-2026$-150M+42% y/y
Leverage Ratio · Consolidated · Q2-2026$3.71
Interest Coverage Ratio · Consolidated · Q2-2026$5.62

Risks flagged

Tariff and Trade Policy Risk

“We continue to monitor the impacts of macroeconomic conditions, including elevated interest rates and inflationary pressures on input costs and consumer behavior, as well as geopolitical uncertainty, including the duration and resolution of ongoing conflicts, potential escalation of tensions and global supply chain disruptions, and ongoing changes to global ” · word for word

Seasonal Concentration Risk

“Due to the seasonal nature of the consumer lawn and garden business, significant portions of our U.S. Consumer and Other segment net sales ship to our retail customers during our second and third fiscal quarters.” · word for word
Read the original on SEC EDGAR ↗
29 Apr 20268-K · 2.02, 7.01Net sales $1.46B (+5% y/y); Gross margin 41.8; Adjusted EBITDA $437M (+9% y/y)earningsopen

Figures in the filing · each found in the filing text

Net sales · Consolidated · Q2-2026$1.46B+5% y/y
Gross margin · Consolidated · Q2-202641.8%
Adjusted EBITDA · Consolidated · Q2-2026$437M+9% y/y
Net income from continuing operations · Consolidated · Q2-2026$263M+19% y/y
Adjusted diluted net income per common share from continuing operations · Consolidated · Q2-2026$4.53+13% y/y

Risks flagged

Discontinued operations loss of $24.7M in Q2 and $102.0M YTD may indicate ongoing restructuring costs

“Loss from discontinued operations, net of tax ($24.7M) Q2, ($102.0M) YTD” · word for word
Read the original on SEC EDGAR ↗
9 Apr 20268-K · 8.01Sale of Hawthorne business to Vireo Growth Inc. for 213M Vireo shares and warrants for 80M additional shares; Hawthorne classified as discontinued operation.being acquiredopen

Risks flagged

Consideration in Vireo shares introduces valuation and liquidity risk; warrants could dilute.

“sold the Company’s Hawthorne business to Vireo for 213 million subordinate voting shares and warrants to acquire 80 million additional Vireo Shares.”
Read the original on SEC EDGAR ↗
20 Feb 20268-K · 2.02Net sales (revised FY2025) $3.26B; Net income from continuing operations (revised FY2025) $182Mearningsopen

Figures in the filing · each found in the filing text

Net sales (revised FY2025) · FY2025$3.26B
Net income from continuing operations (revised FY2025) · FY2025$182M
Read the original on SEC EDGAR ↗
4 Feb 202610-QQ1 FY2026 net sales declined 3.3% YoY, gross margin improved 90 bps, operating loss narrowed 52.4%, and Hawthorne business classified as held for sale with a $104.8M impairment.earningsopen

Figures in the filing · each found in the filing text

Net Sales · Consolidated · Q1-2026$354M-3% y/y
Gross Margin Rate · Consolidated · Q1-202625.0%
Net Loss from Continuing Operations · Consolidated · Q1-2026$-48M
Interest Expense · Consolidated · Q1-2026$27M-20% y/y
Leverage Ratio · Consolidated · Q1-2026$4.03
U.S. Consumer Net Sales · U.S. Consumer · Q1-2026$329M-4% y/y
U.S. Consumer Segment Profit · U.S. Consumer · Q1-2026$9M-8% y/y
Operating Cash Flow · Consolidated · Q1-2026$-370M
Capital Expenditures · Consolidated · Q1-2026$20M-32% y/y

Risks flagged

Hawthorne Discontinued Operations Valuation Risk

“During the three months ended December 27, 2025, we recorded a non-cash pre-tax charge of $104.8 related to a valuation adjustment to recognize the carrying amount of the Hawthorne business at fair value less estimated costs to sell.” · word for word

Seasonal Working Capital and Debt Dependency

“Cash used in operating activities totaled $370.4 for the three months ended December 27, 2025... driven by the timing of inventory production and lower payments to customers related to promotional programs.” · word for word
Read the original on SEC EDGAR ↗
29 Jan 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersopen

Risks flagged

Potential dilution from increased share authorization for incentive plan.

“increase the maximum number of common shares available for grant to participants under the Plan by 2,750,000 Common Shares.” · word for word
Read the original on SEC EDGAR ↗
28 Jan 20268-K · 2.02U.S. Consumer net sales $328M; GAAP gross margin rate 25; Non-GAAP adjusted gross margin rate 25.4; Guidance: Non-GAAP adjusted EPS $4.15-$4.35; free cash flow $275M; gross margin at least 32%earningsopen

Figures in the filing · each found in the filing text

U.S. Consumer net sales · U.S. Consumer · Q1-2026$329M
GAAP gross margin rate · Q1-202625.0%
Non-GAAP adjusted gross margin rate · Q1-202625.4%
GAAP net loss from continuing operations per share · Q1-2026$-0.83
Non-GAAP adjusted net loss from continuing operations per share · Q1-2026$-0.77
Non-GAAP adjusted EBITDA · Q1-2026$3M
Net leverage ratio · Q1-2026$4.03
Share repurchase program authorization$500M

Guidance

Non-GAAP adjusted EPS $4.15-$4.35; free cash flow $275M; gross margin at least 32%

Guidance reaffirmed; divestiture and share repurchase announced; Q1 results in line.

Risks flagged

Hawthorne divestiture consideration in Vireo shares introduces valuation risk.

“Vireo will acquire Hawthorne in exchange for an investment in Vireo” · word for word
Read the original on SEC EDGAR ↗
17 Dec 2025DEF 14AProxy statement seeking shareholder approval for amendment and restatement of Long-Term Incentive Plan, including 2.75M new share authorization, and disclosing insider ownership structure.open

Figures in the filing · each found in the filing text

Common Shares Outstanding · 2025-12-0158,007,149
Potential Fully Diluted Overhang · 2025-12-0112.3%
Hagedorn Partnership Ownership · 2025-12-0122.8%

Risks flagged

Equity Dilution from Share Authorization

“The share authorization after adding the 2,750,000 new Common Shares represents, on a pro forma basis, approximately 12.32% of fully diluted Common Shares of the Company.” · word for word

Governance Risk from Concentrated Ownership

“James Hagedorn ... 23.98%; Katherine Hagedorn Littlefield ... 22.80%; Nathan E. Baxter ... 22.83%”
Read the original on SEC EDGAR ↗
11 Dec 2025SC 13D/ASchedule 13D/A: Hagedorn Partnership, L.P. 23.0%SEC ↗
25 Nov 202510-KNet Sales $3.41B (-4% y/y); Net Income (Loss) $145M; Gross Margin Rate 30.6; Guidance: FY2026 capex guided ~$100M; no revenue or margin guidance providedopen

Figures in the filing · each found in the filing text

Net Sales · Consolidated · FY2025$3.41B-4% y/y
Net Income (Loss) · Consolidated · FY2025$145M
Gross Margin Rate · Consolidated · FY202530.6%
U.S. Consumer Net Sales · U.S. Consumer · FY2025$2.99B-1% y/y
Hawthorne Net Sales · Hawthorne · FY2025$166M-44% y/y
U.S. Consumer Segment Profit · U.S. Consumer · FY2025$573M+15% y/y
Hawthorne Segment Profit (Loss) · Hawthorne · FY2025$3M
Operating Cash Flow · Consolidated · FY2025$371M-44% y/y
Capital Expenditures · Consolidated · FY2025$97M+16% y/y
Leverage Ratio · Consolidated · Q4-2025$4.10

Guidance

FY2026 capex guided ~$100M; no revenue or margin guidance provided

Only capex guidance provided; no revenue or margin outlook. Management tone is neutral with focus on cost savings and innovation.

Risks flagged

Cannabis Oversupply Persistence

“We expect that the oversupply of cannabis will continue to adversely impact our Hawthorne segment.” · word for word

Roundup Agreement Termination Risk

“In the event the Third Restated Agreement for Monsanto’s consumer Roundup products terminates or Monsanto’s consumer Roundup business materially declines, we would lose a substantial source of future earnings and overhead expense absorption.” · word for word

Securities Litigation

“The amended consolidated complaint was filed on May 9, 2025 on behalf of a proposed class of purchasers of Common Shares between May 5, 2021, and August 1, 2023, and asserts claims under Section 10(b), Rule 10b-5 and Section 20(a) of the Exchange Act against the Company and certain of its current and former officers based on alleged misstatements about the C” · word for word

Tariff Exposure

“We are also continuing to monitor ongoing changes to global trade policies, including the imposition of tariffs.” · word for word
Read the original on SEC EDGAR ↗
24 Nov 20258-K · 1.01, 1.02, 2.03Revolving credit facility $1.50B; Term loan $500Mopen

Figures in the filing · each found in the filing text

Revolving credit facility$1.50B
Term loan$500M

Risks flagged

Reduction in total facility size from $2.5B to $2.0B may indicate lower liquidity buffer, but also reflects deleveraging.

“The Sixth Amended and Restated Credit Agreement consisted of ... aggregate amount of $2.5 billion” · word for word
Read the original on SEC EDGAR ↗
21 Nov 2025SC 13D/ASchedule 13D/A: Hagedorn Partnership, L.P. 23.1%SEC ↗
12 Nov 20258-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportSEC ↗
5 Nov 20258-K · 2.02U.S. Consumer net sales $2.99B; GAAP gross margin rate 30.6; Non-GAAP adjusted gross margin rate 31.2; Guidance: Non-GAAP adjusted EPS $4.15-$4.35; free cash flow $275M; gross margin at least 32%earningsopen

Figures in the filing · each found in the filing text

U.S. Consumer net sales · U.S. Consumer · FY2025$2.99B
GAAP gross margin rate · FY202530.6%
Non-GAAP adjusted gross margin rate · FY202531.2%
GAAP earnings per share · FY2025$2.47
Non-GAAP adjusted earnings per share · FY2025$3.74
Non-GAAP adjusted EBITDA · FY2025$581M
Free cash flow · FY2025$274M
Net leverage ratio · FY2025$4.10

Guidance

Non-GAAP adjusted EPS $4.15-$4.35; free cash flow $275M; gross margin at least 32%

FY2025 results beat expectations; FY2026 guidance reaffirms margin expansion and cash flow generation.

Read the original on SEC EDGAR ↗

The Scotts Miracle-Gro Company — questions

What did The Scotts Miracle-Gro Company file recently?
22 SEC filings in the last 12 months. Latest: 8-K on 2026-10-16 — Separation agreement with Christopher Hagedorn, indicating departure of a key officer. No financial details or performance impact stated.

Every figure on this page comes from The Scotts Miracle-Gro Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.